These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2962354)

  • 1. Cellular interactions in graft-v-host disease.
    Parkman R; Champagne J; DeClerck Y; Cooper M; Draper V; Walker S
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):52-4. PubMed ID: 2962354
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell subsets and graft-versus-host disease.
    Korngold R; Sprent J
    Transplantation; 1987 Sep; 44(3):335-9. PubMed ID: 2957834
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional T cell deficits after bone marrow transplantation across minor histocompatibility barriers: effects of graft-vs-host disease on precursor frequency of reactive cells.
    Ferrara JL; Daley JP; Burakoff SJ; Miller RA
    J Immunol; 1987 Jun; 138(11):3598-603. PubMed ID: 3108369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of immune dysfunction associated with minor antigen graft-vs-host disease in mice.
    Hamilton BL; Budhecha S; Hamilton MS; Ochs HD
    Cancer Detect Prev; 1988; 12(1-6):657-62. PubMed ID: 2972364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of long-term transplantation tolerance, chimerism, and host-versus-graft disease: interrelationship and cellular requirements.
    DeNardin AM; Brentjens JR; Andres GA; Nakamura I
    Transplant Proc; 1989 Feb; 21(1 Pt 1):265-6. PubMed ID: 2784894
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
    Williams FH; Thiele DL
    Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell responses to minor histocompatibility antigens.
    Lai PK; Waterfield JD; Gascoigne NR; Sharrock CE; Mitchison NA
    Immunology; 1982 Oct; 47(2):371-81. PubMed ID: 6214502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunologic in vitro studies of kidney and bone marrow transplantation: cytotoxic T cell activity--an advantage or disadvantage?
    Goulmy E
    Transplant Proc; 1988 Apr; 20(2):183-5. PubMed ID: 3284037
    [No Abstract]   [Full Text] [Related]  

  • 9. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens.
    Hamilton BL
    J Immunol; 1987 Oct; 139(8):2511-5. PubMed ID: 3498761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Graft-versus-host disease].
    Chiba S; Nonaka M
    Ryoikibetsu Shokogun Shirizu; 2001; (35):387-9. PubMed ID: 11555965
    [No Abstract]   [Full Text] [Related]  

  • 11. Elicitation of T-lymphocyte responses by major histocompatibility complex encoded determinants.
    Bach FH
    Prog Clin Biol Res; 1984; 149():221-33. PubMed ID: 6204339
    [No Abstract]   [Full Text] [Related]  

  • 12. A model of chronic GVHD.
    Gleichmann E
    Int J Cell Cloning; 1986; 4 Suppl 1():39-41. PubMed ID: 2943827
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis of graft-vs-host disease by adoptive transfer of a class II antigen-specific murine T-cell clone.
    Shih CC; Truitt RL
    Prog Clin Biol Res; 1987; 244():439-47. PubMed ID: 3116558
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect.
    van Rood JJ; Goulmy E; van Leeuwen A
    Prog Clin Biol Res; 1987; 244():433-8. PubMed ID: 3310005
    [No Abstract]   [Full Text] [Related]  

  • 15. Helper function of cytolytic lymphocytes: switching roles in the immune response.
    Li Pira G; Ivaldi F; Bottone L; Koopman G; Manca F
    Eur J Immunol; 2007 Jan; 37(1):66-77. PubMed ID: 17171758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
    van der Meer A; Allebes WA; Voorter CE; van den Berg-Loonen EM; Schattenberg AV; de Witte TJ; Joosten I
    Bone Marrow Transplant; 1998 Dec; 22(11):1049-55. PubMed ID: 9877266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.
    Perreault C; Jutras J; Roy DC; Filep JG; Brochu S
    J Clin Invest; 1996 Aug; 98(3):622-8. PubMed ID: 8698852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
    Kircher B; Niederwieser D; Gächter A; Lätzer K; Eibl G; Gastl G; Nachbaur D
    Ann Hematol; 2004 Sep; 83(9):566-72. PubMed ID: 15170521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular basis of passive enhancement of graft survival.
    Pearce NW; Dorsch SE; Hall BM
    Transplant Proc; 1988 Feb; 20(1):53-5. PubMed ID: 2964113
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease.
    Buhlmann JE; Gonzalez M; Ginther B; Panoskaltsis-Mortari A; Blazar BR; Greiner DL; Rossini AA; Flavell R; Noelle RJ
    J Immunol; 1999 Apr; 162(8):4373-6. PubMed ID: 10201970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.